Proactive Investors - Run By Investors For Investors

Neptune Wellness Solutions thrilled at Tilray extraction agreement

Neptune's wholly owned subsidiary is licensed by Health Canada to process cannabis at its 50,000-square-foot facility
Cannabis plant
Both companies are involved in the cannabis industry

Neptune Wellness Solutions (CVE:NTB) (NASDAQ:NEPT) says it's delighted to be working with cannabis firm Tilray Inc (NASDAQ:TLRY) after it struck a multi-year extraction agreement with the latter.

The health company's wholly owned subsidiary is licensed by Health Canada to process cannabis at its 50,000-square-foot facility located in Sherbooke, Quebec, and will receive cannabis and hemp biomass from Tilray, with which it will create various extracts.

A testament to strength

"We are thrilled to be working with Tilray, a globally recognized leader in cannabis. The size and length of this contract is a testament to the strength of our commercial, scientific and operations teams." said Jim Hamilton, CEO at Neptune.

The minimum amount of biomass to be processed over the three year term is 125,000 kg, of which the first year is expected to represent 20% of total volumes.

Neptune expects to receive its first shipment in September this year.

READ: Tilray unlikely to provide positive earnings until 2020, says Roth analyst

As well as making products for the Canadian and global cannabis markets. Neptune develops and commercializes turnkey nutrition solutions and patented ingredients such as MaxSimil and of a variety of marine and seed oils.

Neptune Wellness shares in Canada zoomed up over 13% on the day to $6.05 each 

Contact Giles at [email protected]

Follow him on Twitter@Gile74

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TLRY profile View Profile

Tilray Inc Timeline

Related Articles

cannabis plant
December 14 2018
The Vancouver-based cannabis group services medical and recreational cannabis markets in Canada and internationally
A cannabis plant shown next to an oil-based product
April 23 2019
THC is executing a medicinal cannabis strategy in Australia, New Zealand and Canada and is looking to Asian markets.
A WeedMD greenhouse
January 21 2019
WeedMD produces cannabis and cannabis oil for both the medical and adult-use markets
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use